¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"drug shock"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® shock ÇÑ±Û ¼îÅ©, Ãæ°Ý
¼³¸í   
  1. Á¤½ÅÀû ÆòÇüÀÇ µ¹¿¬ÇÑ Àå¾Ö. 2. ¾î¶°ÇÑ ¿øÀÎÀ¸·Î ÁøÇ༺ÀΠ¸»ÃʼøÈ¯ºÎÁ·ÀÇ °á°ú·Î Á¶Á÷ÀÇ »ê¼ÒºÎÁ·ÁõÀ» ÀÏÀ¸ÄѠź»ê°¡½º³ª À¯»êµîÀÇ ´ë»ç»ê¹°ÀÇ ÃàÀûÀ» ÀÏÀ¸Å² »óŸ¦ ¸»ÇÑ´Ù. ¼îÅ©ÀÇ ÀÓ»óÁõ»óÀº ¨ç ÇǺÎÀǠâ¹é, ¨è ¼Õ¹ßÅé¸ð¼¼Ç÷°üÀÇ ÀçÃæ¸¸ Áö¿¬, ¨é ÀǽÄÀå¾Ö, ¨ê Ç÷¾ÐÇϰ­, ¸Æ¹Ú±äÀåÀúÇÏ, ¨ë ¿ä·®°¨¼Ò µîÀÌ´Ù. ¼îÅ©ÀÇ ºÐ·ù¿¡´Â 1Â÷¼º¼îÅ©, 2Â÷¼º¼îÅ©°¡ ÀÖÀ¸¸ç ¼øÈ¯µ¿Å¿¡ ÀÇÇÑ ºÐ·ù·Î¼­ ÀúÇ÷·ù·®¼º¼îÅ©, ¸»ÃÊÇ÷°üÈ®À强¼îÅ©, ½ÉÀ强¼îÅ©°¡ ÀÖ´Ù. º´ÀÎÀûÀΠºÐ·ù·Î¼­ ½Å°æÅ¿¼îÅ©, ¾Æ³ªÇǶô½Ã½º¼îÅ©, ±¹¼Ò¸¶Ãë¾à Áßµ¶ÀÇ °á°ú·Î ÀϾ´Â ¼îÅ© µîÀÌ ÀÖ´Ù.
¿µ¹® antihypertensive drug ÇÑ±Û °íÇ÷¾Ð¾à, Ç×°íÇ÷¾ÐÁ¦
¼³¸í   
  °íÇ÷¾ÐÀÇ Ä¡·á¿¡ »ç¿ëÇϸ砳ôÀº Ç÷¾ÐÀ» ³·Ãߴ ¾à¹°À» ¸»ÇÑ´Ù. °íÇ÷¾Ð¾à¿¡´Â Ç÷°üÆòȰ±Ù¿¡ Á÷Á¢ ÀÛ¿ëÇÏ¿© À̿ϽÃ۴ Ç÷°üÈ®ÀåÁ¦(È÷µå¶ó¶óÁø), ±³°¨½Å°æÀǠȰµ¿À» ¾îµð¼±°¡ Â÷´ÜÇϴ ¾à¹°(·¹¼¼¸£ÇÉ, ¸ÞÆ¿µµÆÄ, ÇÁ·ÎÇÁ¶ó³ë·Ñ), ÀÌ´¢Á¦(ÇÁ·Î¼¼¹Ìµå, ¿¡Å¸Å©¸°»ê)ÀÌ »ç¿ëµÈ´Ù.
¿µ¹® antimalarial drug ÇÑ±Û ¸»¶ó¸®¾Æ¾à, Ç׸»¶ó¸®¾ÆÁ¦
¼³¸í   
  ¸»¶ó¸®¾Æ Ä¡·á¿¡ ¾²´Â ¾à. Å°´Ï³×, Å¬·Î·ÎÄý, ÇÁ¸®¸¶Äý µûÀ§°¡ ÀÖ´Ù. ¸»¶ó¸®¾Æ ¿øÃæÀÇ ¹ßÀ°Áֱ⿡ ´ëÀÀÇØ¼­ ¾à¹°ÀÌ ÀÖÀ¸³ª ´ëºÎºÐÀº º´¿ë¿ä¹ý¿¡ µû¶ó¼­ ¸»¶ó¸®¾Æ Ä¡·á¸¦ ÇÑ´Ù. ¸ð±â¿¡ ÀÇÇÑ Æ÷ÀÚü°¨¿°¿¡ ´ëÇÑ Çׯ÷ÀÚü ¾àÀº µ¶¼º µîÀÇ ¹®Á¦°¡ À־ ¾ÆÁ÷ ¾ø´Ù. ÀûÇ÷±¸³»¿¡¼­ÀǠȯ»óü, ¹ø½Äü¿¡¸¸ ÀÛ¿ëÇϴ °Í(Ç×¹ø½Äü ¾àÀº Å¬·Î·ÎÄý, ÇǸ®¸ÞŸ¹Î, Å¬·Î·Î±¸¾Æ³ªÀ̵å, Å°´Ï³×)Àº ÀûÇ÷±¸ ¿ÜÀÇ ¹ßÀ°Àº ¾ïÁ¦ÇÏÁö ¾ÊÀ¸¹Ç·Î °¨¿°À» ¿ÏÀüÈ÷ ÀúÁöµÇÁö ¾Ê´Â´Ù. ÀûÇ÷±¸³»¿ÜÀÇ ¿øÃæ¿¡ ÀÛ¿ëÇØ ¿ÏÀüÈ÷ °¨¿°À» ¾ïÁ¦Çϴ °Í(ÆÄ¸¶Å², ÆæÅ¸Å², ÇÁ¸®¸¶Å²), Ç÷ÁßÀÇ »ý½Äü¸¦ Á×À̴ °Í(´ëºÎºÐÀÇ Ç׸»¶ó¸®¾ÆÁ¦)Àº ¸ð±â¿¡ ÀÇÇѠŸÀÎÀ¸·ÎÀÇ Àü¿°¿øÀº ²÷±â´Âµ¥ È¯ÀÚÀÚ½ÅÀÇ Áõ»óÀº º¯È­ÇÏÁö ¾Ê´Â´Ù.
¿µ¹® drug ÇÑ±Û ¾à, ¾à¹°, ¾àÁ¦
¼³¸í   
  1. º´, ±âŸ º´Àû »óÅÂÀÇ Áø´Ü, Ä¡·á, ¿¹¹æÀ̳ª °íÅëÀÇ °æ°¨, ¶Ç´Â »ý¸®Àû, º´¸®Àû »óŸ¦ È£Àü½Ã۴ °ÍÀ» ¸ñÀûÀ¸·Î »ç¶÷ ¶Ç´Â µ¿¹°¿¡ Åõ¿©µÇ´Â È­ÇÕ¹°. ¾à¸®Çп¡¼­´Â Ä¡·á¾à¸¸ÀÌ ¾Æ´Ï¶ó, »ýü¿¡ ÁÖ¾îÁ³À» ¶§ ¾î¶°ÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»´Â È­Çй°Áú ¸ðµÎ¸¦ ¾à¹°À̶ó°í ÇÑ´Ù. ÀÛ¿ëÀÌ °­ÇÏ°í ¾ÈÀü¼ºÀÌ ³·Àº ¼ø¼­·Î µ¶¾à-±Ø¾à-º¸Åë¾àÀ¸·Î ±¸ºÐÇϰí ÀÖ´Ù. ¾à¹°Ä¡·á¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÀڷμ­, »ýüÂÊ ÀÎÀڷδ °³Ã¼Â÷, ¿¬·É, Ã¼Áß µîÀÌ ÀÖ°í, ¾à¹°ÂÊ ÀÎÀڷμ­´Â Åõ¿©¹æ¹ý, Åõ¿©·®, º´¿ëµÇ°í Àִ ´Ù¸¥ ¾à¹° µîÀÌ ÀÖ´Ù. 2. ¾àÀÇ Àç·á°¡ µÇ´Â ¹°Áú. 3. ¿©·¯ °¡Áö ¾àÀ縦 ¼¯¾î Á¶Á¦ÇÑ ¾à.
¿µ¹® drug resistance ÇÑ±Û ¾à¹°³»¼º
¼³¸í   
  1. È­Çпä¹ýÁ¦³ª Ç×»ý¹°ÁúÀÇ ¾î¶² ÀÏÁ¤ ³óµµ·Î ¼¼±ÕÀ» Á×À̰ųª Áõ½ÄÀúÇØ¸¦ ¹Þ´Â °ÍÀ» ÀÌ È­Çпä¹ýÁ¦³ª Ç×»ý¹°Áú¿¡ °¨¼ö¼ºÀÌ ÀÖ´Ù°í Çϴµ¥, ÀÌ °¨¼ö¼ºÀÌ ¾ø°Ô µÈ »ýŸ¦ ÀúÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. µû¶ó¼­ º¯À̹̻ý¹°ÀÇ ¾àÁ¦¿¡ ´ëÇÑ ÀÚÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. 2. ÀǾàǰÀ» °è¼Ó º¹¿ëÇϸé Á¡Â÷ Áõ·®ÇÏÁö ¾ÊÀ¸¸é È¿·ÂÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¼ºÁú. ÀÌ·¯ÇÑ ¶§¸¦ ¾àÁ¦³»¼ºÀÌ »ý°å´Ù°í ÇÑ´Ù. ¸ðµç ¹Ì»ý¹°Àº °¨¼ö¼ºÀ» °¡Áö´Â ¾à¹°¿¡ ÀÇÇÏ¿© »ç¸êµÇÁö¸¸, ¼Ò¼öÀÇ °ÍÀº »ì¾Æ³²¾Æ ±×°ÍÀÌ ÁøÈ­µÊÀ¸·Î½á »ç¸êÇÏÁö ¾Ê´Â ¼ö°¡ ÀÖ´Ù. ¶Ç, ÃÖÃÊ¿¡´Â °¨¼ö¼ºÀ» °¡Áö°í ÀÖ´ø ±ÕÀÌ Â÷Â÷ ³»¼º±ÕÀ¸·Î µÇ±âµµ ÇÑ´Ù. ¸¹Àº º´¿ø±ÕÀº °¨¼ö¼ºÀÌ Àִ ÀǾàǰ¿¡ ´ëÇÏ¿© ³»¼ºÀÌ »ý±ä´Ù. °¡Àå °íµµÀÇ ³»¼º±ÕÀÌ »ý±â±â ½¬¿î °ÍÀº ½ºÆ®·¾Å丶À̽ÅÀε¥ °áÇÙ±Õ°ú ±×¶÷À½¼º±Õ¿¡ ´ëÇÏ¿© ½±°Ô ³»¼ºÀÌ »ý±ä´Ù. Æä´Ï½Ç¸°À̳ª Åׯ®¶ó½ÃŬ¸°(¾ÆÅ©·Î¸¶À̽Å) µîÀÇ Ç×»ý¹°Áúµµ ³»¼ºÀÌ »ý±â±â ½¬¿ì¹Ç·Î, »ç¿ëÇÒ ¶§´Â ÀûÀÀÀ» Àß È®ÀÎÇÏ¿© Çʿ䷮À» Á¤ÇÏ°í ¿¬¿ëÀ» ÇÇÇÑ´Ù. °°Àº È¿°ú°¡ Àִ ´Ù¸¥ Á¾·ùÀÇ ¾àÁ¦¸¦ ¼Ò·®¾¿ 2, 3Á¾ º´¿ëÇϸ頳»¼ºÀÇ ¹ß»ýÀÌ Å©°Ô ¾ïÁ¦µÈ´Ù´Â °ÍÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. °áÇÙ¾àÀ¸·Î¼­ ½ºÆ®·¾Å丶À̽Űú ÆÄ½º, ¶Ç´Â À̼ҴϾÆÁöµå¸¦ º´¿ëÇϴ °Í µîÀÌ ±× ¿¹ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼îÅ©
  • circulatory shock
    ¼øÈ¯¼îÅ©
  • cold shock
    ÇÑ·©¼îÅ©
  • counter shock
    ¸ÂÃæ°Ý, ¿ªÃæ°Ý
  • culture shock
    ¹®È­Ãæ°Ý
  • cardiogenic shock
    ½ÉÀ强¼îÅ©
  • diastolic shock
    È®Àå±â¼îÅ©
  • extracorporeal shock wave lithotripsy
    ü¿ÜÃæ°ÝÆÄ¼â¼®(¼ú), ¸ö¹ÛÃæ°ÝÆÄµ¹±þ¼ú
  • electric shock
    Àü±âÃæ°Ý
  • electric shock therapy
    Àü±âÃæ°Ý¿ä¹ý
  • endotoxin shock
    ³»µ¶¼Ò¼îÅ©
  • hypoglycemic shock
    ÀúÇ÷´ç¼îÅ©
  • hypoglycemic shock therapy
    ÀúÇ÷´çÃæ°Ý¿ä¹ý, Àν¶¸°Ãæ°Ý¿ä¹ý
  • hypovolemic shock
    ÀúÇ÷·®¼îÅ©
  • heat shock
    ¿­¼îÅ©
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extracorporeal shock wave lithotripsy
    ¸ö¹ÛÃæ°ÝÆÄµ¹±þ¼ú, ü¿ÜÃæ°ÝÆÄ¼â¼®¼ú
  • shock
    ¼îÅ©, Ãæ°Ý
  • hypovolemic shock
    Ç÷¾×·®°¨¼ÒÁõ
  • neurogenic shock
    ½Å°æ¼º¼îÅ©, ½Å°æÅ¿¼îÅ©
  • shock treatment
    Ãæ°ÝÄ¡·á
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
  • antiamebic drug
    ¾Æ¸Þ¹Ù¾à, Ç׾Ƹ޹ÙÁ¦
  • antiarrhythmic drug
    ºÎÁ¤¸Æ¾à, Ç׺ÎÁ¤¸ÆÁ¦
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦
  • antiemetic drug
    ±¸Åä¾à, Ç×±¸ÅäÁ¦
  • antihistaminic drug
    Ç×È÷½ºÅ¸¹ÎÁ¦
  • antihypertensive drug
    °íÇ÷¾Ð¾à, Ç×°íÇ÷¾ÐÁ¦
  • antimalarial drug
    ¸»¶ó¸®¾Æ¾à, Ç׸»¶ó¸®¾ÆÁ¦
  • antiplatelet drug
    Ç×Ç÷¼ÒÆÇÁ¦
  • antiseizure drug
    °æ·Ã¾à, Ç×°æ·ÃÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼îÅ©, Ãʰú¹Î¹ÝÀÀ¼îÅ©
  • shock absorber
    Ãæ°Ý¿ÏÃæ±â
  • bacterial shock
    ¼¼±Õ¼îÅ©
  • cardiogenic shock
    ½ÉÀ强¼îÅ©, ½ÉÀåÅ¿¼îÅ©
  • circulatory shock
    ¼øÈ¯¼îÅ©
  • cold shock
    ÇÑ·©¼îÅ©
  • convulsive shock therapy
    °æ·ÃÃæ°Ý¿ä¹ý
  • counter shock
    ¸ÂÃæ°Ý
  • culture shock
    ¹®È­Ãæ°Ý
  • diastolic shock
    È®Àå±â¼îÅ©, À̿ϱâ¼îÅ©
  • direct current shock
    Á÷·ùÀü°Ý¼îÅ©
  • dye shock
    »ö¼ÒÃæ°Ý
  • electric shock
    Àü±âÃæ°Ý
  • electric shock therapy
    Àü±âÃæ°Ý¿ä¹ý
  • endotoxin shock
    ³»µ¶¼Ò¼îÅ©
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • OTC drug : over-the-counter drug
    ÀϹݸžà.
  • Heat shock protein
    ¿­¼ï´Ü¹éÁú
  • Hypovolemic shock
    Ç÷¾×·®°¨¼Ò(úìäûÕáÊõá´)¼îÅ©
  • Insulin shock
    Àν¶¸°¼ï
  • Irreversible shock
    ºñ°¡¿ªÀû(ުʦæ½îÜ) ¼ï
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã¼º ¼ï, °ú¹Î¼º ¼ï.
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼º ¼ï, °ú¹Î¼º ¼ï.
  • gram negative shock
    ±×·¥À½¼º¼ï.
  • heat shock
    ¿­Ãæ°Ý
  • heat shock protein
    ¿­Ãæ°Ý´Ü¹éÁú
  • heat shock protein
    ¿­Ãæ°Ý ´Ü¹éÁú
  • heat shock protein
    ¿­Ãæ°Ý ´Ü¹é
  • heat shock response
    ¿­Ãæ°Ý¹ÝÀÀ
  • heat-shock protein
    ¿­-Ãæ°Ý´Ü¹é
  • hematogenic shock
    ¿Ü¤ÁÇ÷Ç༺ ¼ï.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug shock
    ¾à¹°Ãæ°Ý(¡­õú̪).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug dependence ; drug dependency
    ¾à¹°ÀÇÁ¸(¼º).
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã¼º ¼ï, °ú¹Î¼º ¼ï.
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼º ¼ï, °ú¹Î¼º ¼ï.
  • bacterial shock
    ¼¼±Õ¼º ¼ï
  • cardiogenic shock
    ½ÉÀμº ¼ï.
  • cardiogenic shock
    ½ÉÀμº¼ï (ãýì×àõ - )
  • cardiogenic shock
    ½ÉÀμº(ãýì×àõ)¼ï
  • cardiogenic shock
    ½ÉÀμº ¼ï(ãýì×àõ ¡­)
  • circulatory shock
    ¼øÈ¯¼º(âàü»àõ) ¼ï
  • circulatory shock
    ¼øÈ¯¼º ¼ï.
  • cold osmotic shock
    ÇÑ·©»ïÅõ¾Ð Ãæ°Ý
  • conditioning shock =c. stimulus
    Á¶°ÇÀÚ±Ø.
  • convulsive shock therapy
    °æ·ÃÃæ°Ý¿ä¹ý(ÌâÕýõú̪èþÛö).
  • convulsive shock therapy =CST
    °æ·Ã¼ï¿ä¹ý(¡­èþÛö).
  • counter shock
    ¿ªÃæ°Ý, Ä«¿îÅͼï.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antiamebic drug
    ¾Æ¸Þ¹Ù±¸ÃæÁ¦
  • antimalarial drug
    Ç׸»¶ó¸®¾ÆÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug-detoxication enzyme
    ¾à¹°Çص¶ È¿¼Ò(å·Úªú°Ô¸ý£áÈ) (ÔÒ) drug-metabolizing enzyme
  • drug-metbolizing enzyme
    ¾à¹°´ë»ç È¿¼Ò(å·ÚªÓÛÞóý£áÈ)
  • drug resistance
    ¾à¹° ÀúÇ×(å·Úªî½ù÷)
  • drug-resistance plasmid
    ¾à¹°ÀúÇ×(å·Úªî½ù÷) Çö󽺹̵å (ÔÒ) R plasmid
  • narcotic drug
    ¸¶¾à(ئå·)
  • psychedelic drug
    ȯ°¢Á¦(ü³ÊÆð¥)
  • radiomimetic drug
    ¹æ»ç¼± ¾ç(À¯»ç) ¾à¹°(Û¯ÞÒàÊåÆ(ëºÞÄ)å·Úª)
  • sulfa drug
    ¼³ÆÄÁ¦(ð¥)
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º ¼îÅ©
  • cold shock
    ³Ã(Ò²) ¼ïÅ©
  • heat shock protein
    ¿­(æð)
  • heat shock puff
    ¿­(æð)
  • heat shock response
    ¿­(æð)
  • insulin shock
    Àν¶¸° ¼ï
  • irreversible shock
    ºñ°¡¿ª(ުʦæ½)¼ï
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
  • drug abuse
    ¾à¹°³²¿ë
  • hypoglycemic shock
    ÀúÇ÷´ç¼º¼ï, Àν¶¸°¼ï
  • narcotic drug
    ¸¶¾à
  • septic shock
    ÆÐÇ÷¼º¼ï
  • shock wave
    Ãæ°ÝÆÄ
  • shock wave lithotripsy
    Ãæ°ÝÆÄ¼â¼®¼ú
  • tuberculostatic drug
    Ç×°áÇÙ¾à
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DA dark adaptation; dark agouti [rat]; daunomycin; degenerative arthritis; delayed action; Dental Assis...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
DAST drug abuse screening test; drug and alcohol screening test
DD dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HSP 2)/heat shock protein
ESWL 2--extracorporeal shock-wave lithotripsy
CS Cardiogenic shock
CSD Cold shock domain
CSP cold shock protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • drug shock
    ¾à¹° Ãæ°Ý
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • circulatory shock
    ¼øÈ¯¼º ¼ï
  • convulsive shock therapy
    °æ·Ã ¼ï ¿ä¹ý
  • diastolic shock
    È®Àå±â ¼ï
  • dye shock
    »ö¼Ò Ãæ°Ý
  • hyperglycemic shock
    °íÇ÷´ç¼º ¼ï
  • neurogenic shock
    ½Å°æ¼º ¼ï, ½Å°æ¿ø¼º ¼ï
  • oligemic shock
    ÇÌÇ÷¼º ¼ï
  • operation shock
    ¼ö¼ú ¼ï
  • pain shock
    µ¿Åë ¼ï
  • physiologic shock absorber
    »ý¸®Àû Ãæ°Ý Èí¼ö´ë
  • post electric shock syndrome
    Àü°Ý ¼ï ÈÄ ÁõÈıº
  • primary shock
    ÀÏÂ÷¼º ¼ï
  • semi-shock
    ¹Ý¼îÅ©
    ´ë»ó ±â±¸°¡ ÀÛ¿ëÇØ, °Ü¿ì ¼îÅ©¸¦ ¸éÇÏ´Â °æ¿ì.
  • shock
    ¼ï
    1. ½Åü ÆòÇüÀÇ °©ÀÛ½º·¯¿î Àå¾Ö. 2. ÁÖ¿ä Àå±â¿¡ ´ëÇÑ Ç÷·ù À¯Áö¸¦ À§ÇÑ ¼øÈ¯°èÀÇ, ±â´É »ó½Ç·Î Ư¡ Áö¿öÁö´Â ½É°¢ÇÑ Ç÷¾× ¼øÈ¯°ú ´ë»çÀÇ ¹æÇØ Á¶°Ç. ÀÌ´Â Ç÷¾×·®ÀÇ ÀúÇÏ·Î ¹ß»ýÇÒ ¼öµµ ÀÖ°í, ½É±â´É ÀúÇÏ È¤Àº ºñÁ¤»óÀûÀÎ vasomotor toneÀ¸·Î ÀÎÇÑ °æ¿ìµµ ÀÖ´Ù. ÀúÇ÷¾Ð, ÇǺÎÀÇ ÇÑ·©, Åë»óÀº ºó¸Æ, Á¾Á¾ ºÒ¾ÈÀ» Ư¡À¸·Î ÇÑ´Ù.
  • shock circuit reaction
    ´Ü¶ô ¹ÝÀÀ
    °¨Á¤Àû Ãæµ¿ÀÌ À̼ºÀÇ ÅëÁ¦¸¦ ¹þ¾î³ª Á÷Á¢À¸·Î Çൿ¿¡ ¿Å°ÜÁö´Â ¹ÝÀÀ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
drug-drug interaction The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity.
(09 Oct 1997)
anaesthetic shock Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage.
(05 Mar 2000)
anaphylactic shock <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing.
(27 Sep 1997)
anaphylactoid shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
break shock The shock produced by breaking a constant current passing through the body.
(05 Mar 2000)
cardiac shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiogenic shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiopulmonary obstructive shock <cardiology> This term describes a number of conditions that involve a severe disturbance of the cardiopulmonary circuit resulting in shock (inadequate delivery of oxygen to the tissues).
Examples include: pulmonary embolism, pericardial tamponade, pneumothorax and constrictive pericarditis.
(27 Sep 1997)
vasogenic shock Shock resulting from depressed activity of the higher vasomotor centres in the brain stem and the medulla, producing vasodilation without loss of fluid so that the container is disproportionately large. In oligaemic shock, blood volume is reduced; in both, return of venous blood is inadequate.
(05 Mar 2000)
reversible shock Shock that will respond to treatment and from which recovery is possible.
(05 Mar 2000)
chronic shock The state of peripheral circulatory insufficiency developing in elderly patients with a debilitating disease, e.g., carcinoma; a subnormal blood volume makes the patient susceptible to haemorrhagic shock as a result of even a moderate blood loss such as may occur during an operation.
(05 Mar 2000)
wet shock A severe condition that occurs when the level of blood glucose (sugar) drops quickly. The signs are shaking, sweating, dizziness, double vision, convulsions, and collapse. Insulin shock may occur when an insulin reaction is not treated quickly enough.
See: hypoglycaemia.
(09 Oct 1997)
cultural shock A form of stress associated with the beginning of an individual's assimilation into a new culture vastly different from that in which he or she was raised.
(05 Mar 2000)
haemorrhagic shock Hypovolaemic shock resulting from acute haemorrhage, characterised by hypotension, tachycardia, pale, cold, and clammy skin, and oliguria.
(05 Mar 2000)
primary shock Shock mainly nervous in nature, from pain, anxiety, etc., which ensues almost immediately upon the receipt of a severe injury.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Food and Drug Administration
    ½Äǰ ÀǾ౹(º¸°Ç ±³À° º¹Áö¼ºÀÇ ÀϺÎ)
  • combination drug
    º¹ÇÕ¾à(2Á¾ ÀÌ»óÀÇ Ç×»ý ¹°Áú µîÀÇ È¥ÇÕ¾à)
  • counter drug
    ÀÇ»çÀÇ Ã³¹æ ¾øÀÌ ÆÇ¸ÅµÇ´Â ¾à
  • drug
    ¾à;¾àÁ¦;¾àǰ;¸¶¾à;~¿¡ ¾àÀ»³Ö´Ù;¸¶Ãë½ÃŰ´Ù;¹°¸®°ÔÇÏ´Ù
  • drug addict
    ¸¶¾à Áßµ¶ÀÚ
  • drug buster
    (¹Ì)¸¶¾à ´Ü¼Ó°ü 
  • drug design
    (¾à)¾àÁ¦ ¼³°è(À¯È¿¼ºÀ» ³ôÀ̱â À§ÇÑ Á¾ÇÕÀû °³¹ß °ËÅä
  • drug interaction
    (¾à)¾à¹° »óÈ£ ÀÛ¿ë
  • drug pump
    (ÀÇ)¾à ÆßÇÁ(Ç÷°ü ÁÖ»ç¿ë)
  • fertillity drug
    ÀӽŠÃËÁøÁ¦
  • garbage drug
    ¿ªÈ¿°ú¸¦ ÃÊ·¡Çϱ⠽¬¿î ¸¶¾à(Á¢ÂøÁ¦³ª ½Ã³Ê µî)
  • hard drug
    ½À°ü¼º ¸¶¾à
  • miracle drug
    Ưȿ¾à;¿µ¾à
  • misbranded drug
    ºÎÁ¤ Ç¥½Ã ÀǾàǰ
  • mood drug
    ±âºÐ ¾à(ÈïºÐÁ¦,ÁøÁ¤Á¦ µî)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á